首页> 外文OA文献 >Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

【2h】

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

机译：快速抗菌易感性试验，用于鉴定针对多药抗性细菌的新治疗和药物组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wei Sun; Rebecca A Weingarten; Miao Xu; Noel Southall; Sheng Dai; Paul Shinn; Philip E Sanderson; Peter R Williamson; Karen M Frank; Wei Zheng;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria [J] . Wei Sun, Rebecca A Weingarten, Miao Xu, Emerging microbes & infections. . 2016,第11期

机译：快速抗菌药敏试验，用于鉴定抗多药耐药细菌的新疗法和药物组合
2. Evaluation of the Accelerate Pheno (TM) system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections [J] . Descours Ghislaine, Desmurs Laurent, Thi Lam Thuy Hoang, European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology . 2018,第8期

机译：评价加速酚类（TM）系统进行血流感染革兰阴性细菌的快速鉴定和抗微生物敏感性试验
3. Advances in rapid identification and susceptibility testing of bacteria in the clinical microbiology laboratory: implications for patient care and antimicrobial stewardship programs [J] . Florian P. Maurer, Martin Christner, Moritz Hentschke, Infectious Disease Reports . 2017,第1期

机译：在临床微生物学实验室中快速鉴定细菌和进行药敏试验的进展：对患者护理和抗菌素管理计划的影响
4. Antimicrobial Peptide May be Desirable Candidate for the Treatment of Multidrug-Resistant Cancer Bacteria: A Simple Introduction to the Therapeutic Effects of A Novel Antimicrobial Peptide Polybia-MPI [C] . Kairong Wang, Bangzhi Zhang, Jiexi Yan, Chinese international peptide symposium . 2011

机译：抗微生物肽可以是治疗多药抗癌和细菌的理想候选者：简单地介绍了一种新型抗微生物肽Polybia-MPI的治疗效果
5. Advances in yeast and mold monodrug and combination drug antifungal susceptibility testing. [D] . Wetter, Tracy Jane. 2004

机译：酵母和霉菌单药及联合用药抗真菌药敏试验的进展。
6. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria [O] . Wei Sun, Rebecca A Weingarten, Miao Xu, 2016

机译：快速抗菌药敏试验用于鉴定抗多药耐药细菌的新疗法和药物组合
7. The bacterial identification and antimicrobial susceptibility testing are usually performed manually. Recently, the number of samples has increased and the need for automatification has grown. BioMerieux has investigated Vitek2 for this purpose. HUSLAB has assigned us to compare the identification and antimicrobial results with respect to routine methods and Vitek2. Furthermore, we evaluate test reactions, ESBL (Extended Spectrum Beta-Lactamase) production and the time what it takes to get results with Vitek2. In this study, we examined a total of 183 bacterial isolates including 76 ESBL-strains, 40 nonfermenting rods, 41 fastidious bacteria and 26 fresh clinical isolates. The results of routine methods were gathered from the patient database and following this, compared to the results given by Vitek2. Vitek2 correctly identified more than 96 f the ESBL-strains and fresh clinical isolates. The results of nonfermenting rods and fastidious bacteri a were 70 oncordant with those of the routine methods. Test reaction results of Api20E were 94 nd Api20NE 70 n concordance with Vitek2 results. Approximately 80 f all Vitek2 antimicrobial results and 90 f ESBL test results were correct. Compared to earlier studies, Vitek2 performed the tests faster than the routine methods. These results suggest that Vitek2 is capable of giving rapid and accurate results. However, nonfermenting rods and fastidious bacteria should be studied further. [O] . Järveläinen Marika, Roslund Iira, Silander Maarit 2006

机译：细菌鉴定和抗菌药敏试验通常是手动进行的。最近，样品的数量增加了，并且对自动化的需求也在增长。 BioMerieux为此进行了Vitek2的研究。 HUSLAB已指派我们比较常规方法和Vitek2的鉴定和抗菌结果。此外，我们还评估了测试反应，ESBL（扩展频谱β-内酰胺酶）的产生以及使用Vitek2获得结果所需的时间。在这项研究中，我们检查了总共183个细菌分离株，包括76个ESBL菌株，40个非发酵棒，41个营养细菌和26个新鲜临床分离株。从患者数据库中收集常规方法的结果，然后将其与Vitek2给出的结果进行比较。 Vitek2正确鉴定出超过96种ESBL菌株和新鲜的临床分离株。与常规方法相比，非发酵棒和精制细菌的结果为70。 Api20E的测试反应结果与Vitek2结果一致为94nd Api20NE 70 n。所有Vitek2抗菌结果约80 f和ESBL测试结果90 f正确。与早期的研究相比，Vitek2的测试速度快于常规方法。这些结果表明Vitek2能够给出快速而准确的结果。但是，应进一步研究非发酵棒和营养细菌。

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

著录项

引文网络

相似文献

相关主题

期刊订阅